BENEV Partner ExoCoBio Secures 3 Additional Exosome U.S. Patents
MISSION VIEJO, Calif., March 13, 2023 /PRNewswire/ — BENEV Company Inc., an FDA registered manufacturer with a global presence, is proud to announce that their strategic partner, ExoCoBio has secured 3 additional patents1 in the U.S. for their Exosome products relating to: These patents join 3 others that protect the intellectual and clinical rights to an important advancement […]